Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ocubless Plus is an oral multivitamin, multimineral, and antioxidant dietary supplement developed and marketed by Centaur Pharmaceuticals. Formulated as a tablet, it is designed to support eye health, healthy vision, and retinal and macular wellness, particularly in individuals with or at risk of age-related macular degeneration (AMD). The formulation contains a comprehensive blend of essential carotenoids (lutein and zeaxanthin), vitamins (including vitamins A, B-complex, C, D2, E, and K2), and minerals (such as calcium, zinc, copper, magnesium, manganese, chromium, selenium, and molybdenum). These components work synergistically to provide antioxidant protection, neutralize free radicals, filter harmful blue light, and maintain overall nutritional balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ocubless Plus.